Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct-Dec;14(4):287-293.

Bioactive Materials Derived from Menstrual Blood Stem Cells Enhance the Quality of In Vitro Bovine Embryos

Affiliations

Bioactive Materials Derived from Menstrual Blood Stem Cells Enhance the Quality of In Vitro Bovine Embryos

Mohammad Sobhan Amini et al. Avicenna J Med Biotechnol. 2022 Oct-Dec.

Abstract

Backgrounds: The aim of this study was to determine whether the addition of bioactive materials derived from Menstrual Blood Stem Cells (MenSCs) to the oocyte maturation medium may improve the quality of bovine embryos in vitro.

Methods: MenSCs were collected from 6 healthy women (between 26 and 36 years old) and after 3 days of culture, their bioactive materials were frozen. The bovine Cumulus-Oocyte-Complexes (COCs) were aspirated from ovarian slaughterhouse and the oocytes with more than three layers of cumulus cells were cultured in vitro in media supplemented with (treatment) and without (control) 10% MenSCs' bioactive materials. After IVM/IVF, the presumptive zygotes were cultured for 8 days.

Results: The blastocyst rate on day 8 in treatment group was higher than control (40.2±1.9 vs. 23±4.2.3, p=0.001). The ratio of Trophectoderm (TE) and Inner Cell Mass (ICM) (ICM/TE) cells was also greater in treatment group compared to control (30.3±2 vs. 14.9±1; p=0.001). The re-expansion of vitrified blastocysts, 24 hours after warming, in treatment group was higher than control (93.3±2.5 vs. 66.2±8.8; p=0.01). The expression of some genes related to pluripotency and implantation (OCT4, CDX2, and IFNT) were increased in treatment group compared to control (p<0/05).

Conclusion: In conclusion, the addition of MenSCs' bioactive materials during in vitro maturation of bovine oocytes could improve the quantity and quality of bovine IVP embryos. Also, the expression of some genes associated with pluripotency and implantation in the blastocyst would be increased.

Keywords: Bovine; Embryo; IVM; In vitro production; Menstrual blood stem cells.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Effects of MenSCs’ bioactive materials on expression of Nanog, Bax, OCT4, CDX2, and IFNT genes.

Similar articles

Cited by

References

    1. Moore SG, Hasler JF. A 100-Year Review: Reproductive technologies in dairy science. J Dairy Sci 2017; 100 (12): 10314– 31. - PubMed
    1. Nejat-Dehkordi S, Ahmadi E, Shirazi A, Nazari H, Shams-Esfandabadi N. Embryo co-culture with bovine amniotic membrane stem cells can enhance the cryo-survival of IVF-derived bovine blastocysts comparable with co-culture with bovine oviduct epithelial cells. Zygote 2021; 29 (2): 102– 7. - PubMed
    1. Shadmanesh A, Nazari H, Shirazi A, Ahmadi E, Shams-Esfandabadi N. Human amniotic membrane stem cells' conditioned medium has better support for in-vitro production of bovine embryos than FBS. Reprod Domest Anim 2022; 57 (2): 173– 84. - PubMed
    1. Sena-Netto SB, Sprícigo JFW, Leme LO, Guimarães ALS, Caixeta FMC, Dode MAN, et al. . The replacement of fetal bovine serum with bovine serum albumin during oocyte maturation and embryo culture does not improve blastocyst quality after slow freezing cryopreservation. Biopreserv Biobank 2020; 18 (3): 171– 9. - PubMed
    1. Holm P, Callesen H. In vivo versus in vitro produced bovine ova: similarities and differences relevant for practical application. Reprod Nutr Dev 1998; 38 (6): 579– 94. - PubMed

LinkOut - more resources